Unapproved Medical Devices and Uses

Since 1976, the FDA has had the responsibility to be the medical device gatekeeper, approving or clearing devices for interstate commerce. Unfortunately, the bureaucratic agency has not been able to keep up with the rapidly changing medical device landscape. Too, the FDA regulatory gates have been pried open by Congress, leading to a flood of medically-questionable devices in the market.

According to one expert, “Many high-risk medical devices today are approved on the basis of just one clinical trial (as opposed to new medications which usually require two trials).  And only a small minority of clinical studies of medical devices are randomized, controlled and blinded—the gold standard for reliable evidence (and the benchmark to which studies of drugs are held).”

Even in this lenient environment, many medical device manufacturers are finding it necessary to cheat the FDA, either by fabricating pivotal trial results or by otherwise misrepresenting factual data in the FDA approval or clearance processes. These actions may subject the manufacturer to liability under the False Claims Act and the federal Food, Drug and Cosmetic Act (FDCA).

Under the FDCA, every manufacturer of a medical device is required to obtain authorization from the FDA prior to marketing its device, unless the devices are subject to certain rare exemptions. If the manufacturer intends to market a previously cleared device for a new or different indication for use other than the intended use cleared by the FDA, a new marketing authorization is required. While physicians may prescribe medical devices for unapproved uses, a manufacturer may not distribute medical devices in interstate commerce with the intent that those devices be used for unapproved purposes.

By filing successful qui tam actions against manufacturers that engage in FDA fraud, Nolan Auerbach & White has been at the forefront in helping the government recoup hundreds of millions of healthcare dollars wasted on unapproved drugs. The Firm has also scrutinized the same devious business practices in medical device industry, in which manufacturers market their devices without FDA approval or for uses not approved or cleared by the FDA. Given that many of these devices are used in medically invasive procedures, the Firm and the federal government have a special interest in exposing these manufacturers.

REAL PEOPLE making real change Medical Equipment Fraud Wins

Kathleen Hawkins

Dignity Health
$37 million

Kathleen Hawkins, RN MSN, had been employed by Defendant, Catholic Healthcare West (CHW) for approximately 6 years when she decided she had had enough of trying to change the hospital system from within.

CHW, a California not-for-profit corporation that operated hospitals in California, Arizona, and Nevada, was at the time the eighth largest hospital system in the nation and the largest not-for-profit hospital provider in California.

READ MORE

Joe Strom

Johnson & Johnson
$184 Million

Joe Strom contacted us in 2005. We were very grateful that he did. We immediately formed an all-star legal team and a process to stop a very harmful pharmaceutical marketing strategy. It was this process we set into motion that ultimately returned hundreds of millions of dollars to the U.S. Treasury, and a portion of that, very well-deserved, into Joe’s bank account.

Joe told us a very troubling story about the off-label promotion of a pharmaceutical drug for patients who already suffered from chronic heart failure.

READ MORE

Description
Description

“I collaborated with Nolan, Auerbach and White on a broad variety of cases where whistleblowers stepped forward to disclose tactics employed by large companies to influence physicians' medical decision-making in patient care. They and their medical consultants, have consistently leveraged biomedical research and best medical evidence to advance patient safety, optimize clinical outcomes, and control precious resource utilization.”

— Fred Polsky M.D.,, Former Medical Director, CMS Zone 7 Integrity Contractor

Any Questions?

Am I potential whistleblower that matches up well with our firm?

We only want to represent amazing people.

How much will I make?

We cannot guarantee anything, but we will deliver on this promise: we will give you feedback and a prognosis within 48 hours of your submission of all details to us. We are the first healthcare fraud qui tam law firm, and have been doing only healthcare fraud whistleblower lawsuits for decades-so you can expect as accurate a picture as is possible.

Are my communications with you confidential?

They are 100% confidential. If we do not take your case, your information becomes inaccessible. We have no interest in it. Besides, it is protected by the attorney-client privilege under our lawyer regulations, and we would lose our license if we were to disclose one iota of information about you or your potential case.

    Contact Us

    Contact Us

    The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. IF IT DOES, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

    No. of Employees at the Company?
    Please read the following statement and then click "Send Form":

    Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.